Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Malignant Solid Neoplasm 2Colorectal Neoplasms 2Rectal Neoplasms 1Pain 1Neoplasm Metastasis 1Lymphoma, B-Cell 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Fatigue 1Colonic Neoplasms 1Burkitt Lymphoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1Acquired Immunodeficiency Syndrome 1

Interventions

Fluorouracil 20Leucovorin 18Oxaliplatin 11Irinotecan 10Capecitabine 6Bevacizumab 5Cetuximab 4Levamisole 3Celecoxib 3cediranib 2Watchful Waiting 2Tegafur 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Folfox protocol 2Counseling 2Cisplatin 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1regorafenib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1gevokizumab 1eniluracil 1cemiplimab 1brivanib 1alpha-Tocopherol 1Vitamin E 1Uracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colonic Neoplasms × Interviews as Topic × Clear all
NCT00410579 2010-12-17

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NSABP Foundation Inc

Completed
744 enrolled
Gastrointestinal

Colonic Neoplasms, Fatigue, Pain, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡